Hinge Bio to receive $10 million upfront and is eligible to receive $95 million for the SLE indication and additional payments for other indications; includes contingent R&D investment, tiered sales ...

Bio-Techne Corporation TECH recently announced new advancements in its spatial biology portfolio for the RNAscope ISH technology and the Lunaphore COMET. Research highlights the potential role of ...

New preclinical data demonstrate deeper IgA reduction and a longer half-life compared to first-generation anti-APRIL ...

Purpose of Study: The purpose of this study is to establish the safety and potential effectiveness of investigational FT819 in participants with moderate to severe systemic lupus erythematosus (SLE) ...

Objective Inflammation and repair responses may be involved in atherosclerosis in rheumatoid arthritis (RA), although ...

Aera Therapeutics, a biotechnology company harnessing next-generation enabling delivery technologies and precision payloads to unlock the full potential of genetic medicines, today presented ...

Background: B-cell activating factor (BAFF) is crucial for B-cell survival, proliferation, and immunoglobulin secretion. However, its role in hematopoietic malignancies, particularly concerning B-cell ...

Background Intrahepatic cholangiocarcinoma (iCCA) is a highly aggressive biliary tract cancer with a poor prognosis and a complex tumour microenvironment (TME) that remains poorly understood.

Sonrotoclax shows promise as a new treatment for relapsed/refractory mantle cell lymphoma, achieving significant response rates in heavily pretreated patients. The phase 1/2 BGB-11417-201 study ...

B lymphocytes (B-cells) are a type of white blood cell important for immune function. They develop from stem cells through several stages. Malignancies in this lymphoid lineage can lead to acute ...

ctDNA-MRD assay offers superior prognostic value over traditional imaging in LBCL, predicting outcomes more accurately than PET/CT scans. PhasED-Seq ctDNA testing demonstrated high sensitivity and ...